Number of the records: 1  

Efficacy and tolerability of an endogenous metabolic modulator (AXA1125) in fatigue-predominant long COVID: A single-centre, double-blind, randomised controlled phase 2a pilot study

  1. TitleEfficacy and tolerability of an endogenous metabolic modulator (AXA1125) in fatigue-predominant long COVID: A single-centre, double-blind, randomised controlled phase 2a pilot study. textový dokument (print)
    Author Finnigan L.E.M.
    Co-authors Cassar M.P.

    Koziel M.J.

    Pradines J.

    Lamlum H.

    Azer K.

    Kirby D.

    Montgomery H.

    Neubauer S.

    Valkovič Ladislav 1986 SAVMER - Ústav merania SAV    SCOPUS    RID    ORCID

    Raman B.

    Source document eClinicalMedicine. Vol. 59 (2023), art. no. 101946
    Languageeng - English
    CountryGB - Great Britian
    Document kindrozpis článkov z periodík (rbx)
    CitationsBOYARCHUK, O. - VOLIANSKA, L. Autoimmunity and long COVID in children. In REUMATOLOGIA. ISSN 0034-6233, 2023, vol. 61, no. 6, p. 492-501. Dostupné na: https://doi.org/10.5114/reum/176464.
    GANDJOUR, A. Long COVID: Costs for the German economy and health care and pension system. In BMC HEALTH SERVICES RESEARCH. JUN 14 2023, vol. 23, no. 1. Dostupné na: https://doi.org/10.1186/s12913-023-09601-6.
    TSILINGIRIS, D. - VALLIANOU, N.G. - KARAMPELA, I. - CHRISTODOULATOS, G.S. - PAPAVASILEIOU, G. - PETROPOULOU, D. - MAGKOS, F. - DALAMAGA, M. Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges. In INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. ISSN 1661-6596, JUL 2023, vol. 24, no. 13. Dostupné na: https://doi.org/10.3390/ijms241310458.
    BRIGHTLING, C.E. - EVANS, R.A. - SINGAPURI, A. - SMITH, N. - WAIN, L. Long COVID research: an update from the PHOSP-COVID Scientific Summit. In LANCET RESPIRATORY MEDICINE. ISSN 2213-2600, 2023 NOV 2023, vol. 11, no. 11, p. E93-E94. Dostupné na: https://doi.org/10.1016/S2213-2600(23)00341-7.
    LEPKOWSKY, C.M. U.S. COVID-19 Policy in 2023 and its Consequences. In MEDICAL RESEARCH ARCHIVES. ISSN 2375-1924, 2023, vol. 11, no. 6. Dostupné na: https://doi.org/10.18103/mra.v11i6.4022.
    CategoryADCA - Scientific papers in foreign journals registered in Current Contents Connect with IF (impacted)
    Category of document (from 2022)V3 - Vedecký výstup publikačnej činnosti z časopisu
    Type of documentčlánok
    Year2023
    Registered inWOS
    Registered inSCOPUS
    Registered inCCC
    DOI 10.1016/j.eclinm.2023.101946
    article

    article

    File nameAccessSizeDownloadedTypeLicense
    Efficacy and tolerability of an endogenous metabolic modulator .pdfavailable936.8 KB5Publisher's version
    rokCCIFIF Q (best)JCR Av Jour IF PercSJRSJR Q (best)CiteScore
    A
    rok vydaniarok metrikyIFIF Q (best)SJRSJR Q (best)
    2023202215.1Q14.553Q1
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.